Does Coriolus Versicolor Work as Lung Cancer Treatment

A study has found evidence that the bioactive compounds from the versatile medicinal mushroom coriolus versicolor slows the progression of lung cancer, with hope for improved anti-cancer treatments in the future. Does Coriolus Versicolor work as lung cancer treatment?

Non-small cell lung cancer is one of the leading causes of all cancer deaths. Non-small cell lung cancer is the most common type of lung cancer, making about 85% of all lung cancers. Smoking tobacco is one of the main risk factors for developing lung cancer, though it has also been diagnosed in non-smokers. However, quitting smoking is the best way to reduce your risk of developing lung cancer.

Lung cancer is treated by surgery, radiation therapy, chemotherapy, and other targeted therapies. If the cancer spreads, or metastasizes, it may not be able to be cured, but it could still be treated. Treatments for advanced cancer aim to increase quality of life, rather than cure the cancer.

Study developed to test Coriolus Versicolor effects on advanced lung cancer

Coriolus Versicolor Medicinal Mushroom May Help with Lung Cancer

Coriolus Versicolor May Help Patients with Lung Cancer

The study, by researchers Tsang KW, Lam CL, et al, from the University of Hong Kong, investigated polysaccharide peptides extracted from coriolus versicolor, also known as the turkey tail mushroom. This mushroom is a popular supplement, and has been used by many people as an additional treatment for cancer, along with the conventional treatments. Coriolus versicolor is currently the subject of many scientific trials into its anti-cancer effects.

In this study, the polysaccharide peptides from the mushroom were tested in a double-blind, placebo-controlled randomized study of 34 patients with advanced non-small cell lung cancer.

Coriolus Versicolor lung cancer study results

The study analyzed the blood, serum, and body fat of patients with non-small cell lung cancer who had completed conventional treatments. There was a significant improvement for the coriolus versicolor group compared to the control group not given coriolus versicolor. The mushroom’s polysaccharide peptides slowed deterioration in the lung cancer patients.

The researchers hope that in the future improved cancer treatments using coriolus versicolor could be developed to prolong the life of lung cancer patients.


The author of this story is a freelance contributor to National Nutraceuticals’ online news portals, such as Amino Acid Information Center at and Vancouver Health News at  National Nutraceuticals, Inc. also owns and operates a third health news portal focusing on medicinal mushrooms at, plus our newest portal at

If you like our news sites and would like to have your own one, contact Zorilla Marketing at We specialize in building online news portals and provide content marketing services.





Bridget Greenwood


No comments!

There are no comments yet, but you can be first to comment this article.

Leave reply

Your email address will not be published. Required fields are marked *